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The term ‘‘afferent neurourology’’ is introduced to describe the study of sensory processing related to the genitourinary
tract. Urologic disorders that are characterized by abnormal sensory processing are reviewed, and unique challenges
to our understanding of these disorders are described. A paradigm which separates afferent urologic disorders
from efferent disorders and structural abnormalities is presented. Neurourol. Urodynam. 29:S29–S31, 2010.
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INTRODUCTION
The field of neurourology may be succinctly defined as the
study of normal lower urinary tract neurophysiology, as well
as functional urologic abnormalities resulting from neurologic
disease or injury. Many neurologic disorders can adversely
affect urinary tract function, including congenital disorders
(spina bifida), systemic diseases (multiple sclerosis), and
localized injuries (cerebrovascular accident, traumatic spinal
cord injury).1 The urologic management of these patients
focuses on improving continence and preventing upper
urinary tract complications. Management principles are well
established, and include a variety of non-surgical and surgical
techniques to reduce reflex detrusor activity and maintain low
bladder storage pressures.2,3 These techniques are primarily
focused on identifying and modulating motor (efferent)
neurologic activity.
There exists an entirely different group of ‘‘urologic’’
abnormalities which are characterized by pain and/or urinary
urgency. A variety of diagnoses can be assigned to these
symptoms (Table I). However, these diagnostic labels are
largely based on clinical criteria rather than on objective criteria.
Therefore, such diagnoses are likely to have poor reliability
and validity. Many of these disorders are characterized as
infectious or inflammatory conditions,4,5 even though current
evidence suggests that neither infection nor inflammation is
involved in the etiology of the symptoms. Instead, it may be
more appropriate to consider these conditions as urologic
manifestations of sensory neurologic dysfunction.
PROPOSED TERMINOLOGY
The term afferent neurourology is proposed. This term
refers to the field of study concerned with the processing of
sensory information related to the genitourinary (GU) tract.
This includes sensory processing within the GU tract as well as
sensory data from the GU tract which is processed elsewhere
within the peripheral and central nervous system. Further-
more, it is acknowledged that many afferent signals are not
perceived at the conscious level but they still play a vital role
in afferent neurourology as it relates to lower urinary tract
physiology. Inclusive in this concept is that abnormal
processing of sensory information related to the GU tract
results in distressing symptoms and healthcare seeking. The
term afferent urologic disorders is used to describe the various
clinical terms that are often employed to categorize these
symptoms (Table I). Certain clinical disorders (e.g., vulvodynia,
endometriosis) are excluded, as they are typically not
managed by urologists. However, such disorders could
potentially be included in a broader term such as ‘‘Afferent
Pelvic Disorders.’’
AFFERENT NEUROUROLOGY—SYMPTOMS
Abnormal processing of sensory information related to the
GU tract results in pain and/or urgency. The International
Association for the Study of Pain (IASP) defines pain as an
‘‘unpleasant sensory or emotional experience associated with
actual or potential tissue damage, or described in terms of
such damage.’’6 From a urologic standpoint, pain can be from
bladder or non-bladder sources. This categorization is relevant
because bladder pain is significantly more difficult to describe
and characterize than non-bladder pain (see below). The Inter-
national Continence Society defines urgency as the ‘‘sudden
compelling desire to pass urine, which is difficult to defer.’’7 It
could potentially be argued that this commonly accepted
definition of urgency may in fact meet the IASP criteria for
pain presented above. However that interpretation is certainly
open to debate, and the inclusion of urgency as a separate
symptom component within the afferent neurourology
paradigm seems to be appropriate at this time.
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Nocturia and urinary frequency are additional bothersome
symptoms that are a frequent cause of urology clinic visits.
However, these two symptoms are actually behaviors that are
driven by urinary urgency, bladder pain, and/or many other
factors.8 For instance, frequency and nocturia may occur in
individuals with completely normal urinary tracts who drink
excessive amounts of fluid. For this reason, nocturia and
frequency are not included as symptom components within
the afferent neurourology paradigm.
BLADDER PAIN VERSUS URGENCY
The distinction between various afferent urologic disorders
is not always clear. For instance, the criteria used to differ-
entiate interstitial cystitis/painful bladder syndrome (IC/PBS)
from overactive bladder (OAB) have received considerable
attention.9,10 The hallmark symptom of IC/PBS is pain that is
referable to the bladder,7,11 while the hallmark symptom of
OAB is urgency.7 However, some individuals with a diagnosis
of IC/PBS deny the presence of pain, but instead refer to their
symptoms as ‘‘pressure’’ or ‘‘discomfort’’ or ‘‘urgency.’’12,13
This observation has caused some to differentiate between
‘‘urgency’’ (which would identify OAB), and ‘‘persistent urge to
void’’ (which would be more consistent with IC/PBS symp-
toms).11 Others have stated that the urgency in OAB is
characterized by fear of leakage, while the urgency of IC/PBS
is due to pain, pressure, or discomfort.9,10 The problem with
these categorization efforts is that there will invariably be
individuals who defy categorization, regardless of the cat-
egory that is chosen. For example, in a study of 180 women
with incident IC/PBS diagnoses, fully 21% reported urinary
urgency due to a fear of leakage, and an additional 9%
indicated no urgency at all.14 Also, in the Interstitial Cystitis
Database study, approximately 15% of individuals with a
clinical diagnosis of IC/PBS had urodynamic evidence of
detrusor overactivity.15 Finally, it is the author’s personal
observation that some individuals with classic OAB symptoms
will describe their urgency as ‘‘painful.’’ Until meaningful
patient subgroups can be differentiated based on objective
data that are tied to a known pathophysiologic process, it may
be preferable to avoid arbitrary diagnoses and instead focus
on symptom descriptions.16,17
AFFERENT, EFFERENT, AND STRUCTURAL ABNORMALITIES
Conceptually, afferent urologic disorders can be differ-
entiated from efferent and structural abnormalities (Table II).
Examples of efferent (motor) abnormalities include detrusor
overactivity/urge incontinence, detrusor sphincter dyssyner-
gia, diminished bladder compliance (due to increased detrusor
muscle tone), detrusor failure, and dysfunctional voiding
(pseudodyssynergia). Examples of structural abnormalities
include stress urinary incontinence, pelvic prolapse, dimin-
ished bladder compliance (due to bladder wall fibrosis),
urinary fistulas, and anatomic bladder outlet obstruction.
There is clearly a relationship between the afferent
symptom of urgency and the efferent condition of urge
incontinence/detrusor instability, but this relationship is not
well understood. For instance, urge incontinence/detrusor
overactivity does appear to include dysfunction of the
prefrontal cortex and/or abnormal afferent signaling in at
least some patients. The condition OAB is often subcategorized
into ‘‘OAB dry’’ (urgency without urge incontinence) and ‘‘OAB
wet’’ (urgency with urge incontinence). These two subgroups
are considered part of an OAB disease spectrum, but it is not
known if they in fact share the same underlying pathophysi-
ology. It is also unclear to what extent those with ‘‘OAB dry’’
progress to ‘‘OAB wet.’’ Furthermore, the mechanism respon-
Neurourology and Urodynamics DOI 10.1002/nau
TABLE I. Afferent Neurourology—Disorders
Interstitial cystitis/painful bladder syndrome/bladder pain syndrome
Bladder pain, pressure, or discomfort
Chronic prostatitis/chronic pelvic pain syndrome (NIH Type III prostatitis)
Penile pain, perineal pain, pain with ejaculation
Overactive bladder























Diminished bladder compliance (fibrosis/scar)
Anatomic bladder outlet obstruction






























sible for converting the afferent symptom of urgency to the
efferent symptom of urge incontinence is not well understood.
It is notable that each of the efferent and structural
abnormalities has an objective diagnostic test which can be
used to confirm the diagnosis and quantify its severity.
Conversely, the afferent urologic disorders currently have no
objective tests which can confirm the diagnosis, identify
specific subgroups of patients, or provide prognostic informa-
tion. This may be one reason why these disorders have
received little attention in the literature (Table III). Urgency
and pain could theoretically be caused by abnormal sensory
processing within the GU tract or by abnormal processing of
sensory data from the GU tract, or a combination of both.
OVERLAP OF AFFERENT, EFFERENT,
AND STRUCTURAL ABNORMALITIES
Clinicians will quickly recognize that multiple afferent,
efferent, and structural disorders may be present in an
individual patient (Fig. 1). For example, certain women may
present with stress incontinence (structural), poor detrusor
contractility (efferent), and bladder pressure/pain (afferent).
Men may present with anatomic bladder outlet obstruction
due to prostatic hyperplasia (structural), detrusor overactivity
(efferent), and perineal pain (afferent). The clinical manage-
ment is fairly straightforward in patients with symptoms in a
single category (afferent, efferent, or structural), but becomes
increasingly complex as they manifest symptoms in addi-
tional categories. It seems reasonable to conclude that
effective patient management requires recognition of this
overlap when it occurs.
CONCLUSION
The term ‘‘afferent neurourology’’ can be used to describe
the processing of sensory information related to the GU tract.
Abnormal sensory processing (within the GU tract or
centrally) causes symptoms of pain and urinary urgency.
Patients with these symptoms are often diagnosed with
‘‘interstitial cystitis,’’ ‘‘prostatitis,’’ or ‘‘overactive bladder’’
although these diagnoses are fraught with problems. These
afferent urologic symptoms often overlap with efferent
symptoms and structural abnormalities, and effective patient
management requires an awareness of this.
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Fig. 1. Overlap of urologic conditions.
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